Cutaneous Melanoma Recruiting Phase 1 / 2 Trials for Binimetinib (DB11967)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03947385Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsTreatment